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Abstract Seminalplasmin (SPLN) is a 47-residue protein 
isolated from bovine seminal plasma having potent antimicrobial 
activity against a broad spectrum of microorganisms. SPLN, 
also known as caltrin, acts as a calcium transport regulator in 
bovine sperms. Analysis of the sequence of SPLN reveals a 27-
residue stretch with the sequence SLSRYAKLANRLANPKL-
LETFLSKWIG more hydrophobic than the rest of the protein. It 
is demonstrated that a synthetic peptide corresponding to this 27-
residue segment has antimicrobial activity comparable to that of 
SPLN. It does not exhibit hemolytic activity at concentrations 
where antibacterial activity is observed. Since P27 can be 
conveniently obtained in large amounts by chemical synthesis, it 
could serve not only as a starting compound to obtain peptides 
with improved antibacterial activity but also to understand the 
role of SPLN in reproductive physiology. 
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1. Introduction 
There has been considerable interest in determining the 
constituents of seminal plasma possessing antimicrobial activ-
ity from as early as 1949, following the observation that it had 
the ability to inhibit the growth of S. aureus [1,2]. The un-
equivocal demonstration of the presence of a small molecular 
weight, non-enzymatic protein in bovine seminal fluid came 
from the isolation and characterization of seminal plasmin 
(SPLN), a 47-residue peptide [3-5]. Antibacterial peptides 
have been shown to play an important role in the innate 
immunity of many animal species [6]. Antibacterial peptides 
also appear to be present in the reproductive tract. The gene 
for a putative 39-residue antibacterial peptide F ALL-39 is 
expressed in human testis [7]. A 32-residue antibacterial pep-
tide andropin has been characterized from ejaculatory duct of 
Drosophila [8]. The female accessory sex gland of the medfly 
Ceratitis capitata has been found to contain two 29-residue 
antibacterial peptides: ceratotoxins A and B [9]. Thus, the 
presence of antimicrobial peptides in the reproductive tract 
may serve an important function in offering protection against 
infection. SPLN exhibits antimicrobial activity against a vari-
ety of microorganisms [3,10]. The peptide also exhibited spe-
cificity in activity, i.e., it did not have hemolytic activity over a 
wide concentration range [11,12]. Interestingly, the peptide 
specifically lysed dividing cells in culture [II]. We have been 
interested in mechanisms by which SPLN exerts its activity. 
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Several lines of evidence suggest that SPLN exerts its activity 
by permeabilizing the bacterial membranes [13] very much like 
the subsequently discovered endogenous antibacterial peptides 
from species right across the evolutionary scale like cecropins, 
defensins and magainins [6,14,15]. Since the interaction of 
SPLN with lipids appears to be important in the manifesta-
tion of its activity, the sequence of SPLN was analysed in 
order to delineate segments that would conceivably have a 
high potential to interact with lipids [12,16]. Two 13-residue 
stretches corresponding to 14-26 and 28-40 regions of SPLN, 
i.e., SLSRY AKLANRLA (SLS) and PKLLETFLSKWIG 
(SPF) (Fig. 1) having a good propensity to interact with lipids 
were identified [12]. We have investigated the activity of a 27-
residue peptide, P27, with the sequence SLSR Y AKLANR-
LANPKLLETFLSKWIG, encompassing both the 13-residue 
segments SLS and SPF. The results of our investigations are 
described in this paper. 
2. Experimental procedures 
2.1. Peptide preparation 
Peptide P27 was synthesized by Fmoc chemistry on a Milligen 
Peptide Synthesizer and the peptide-bound resin was kindly provided 
by Dr. K.R. Kumaraswamy of Millipore (India) Pvt. Ltd. The peptide 
was cleaved from the resin with trifluoroacetic acidlthioanisole/meta-
cresollethanedithiol (10: I : 1:0.5, v/v). The crude peptide was purified 
by HPLC on a Bio-rad (Hi-Pore RP 304) C4, 250X4.6 mm column 
using the solvents A (H20 containing 0.1% TFA) and B (CH3CN 
containing 0.1% TFA). A linear gradient of 0-100% in 60 min at a 
flow rate of I mllmin was used. The desired peptide eluted at - 26.5 
min. Composition of the peptide was checked by amino acid analysis 
on a LKB 4151 Alpha Plus Amino Acid Analyzer and was sequenced 
on an Applied Biosystems 473A Protein Sequencer. 
2.2. Antimicrobial activity 
The antimicrobial activities of the peptides were assayed by proce-
dures described earlier under aerobic conditions [17]. Different con-
centrations of peptide were added to I ml of nutrient broth medium 
containing the inocula of test organism, in mid-logarithmic phase of 
growth, - 106 CFU/ml. The nutrient broth contained 6 g of bacto 
nutrient broth (Difco) and 5 g of NaCI per liter. Microbial growth 
was determined by the increase in OD6oo after incubation of the sam-
ples at 37°C or 30°C for 6-9 h. The lowest concentration that resulted 
in complete inhibition of growth was recorded as 100% minimal in-
hibitory concentration (MIC). The microorganisms were E. coli, S. 
aureus, P. aeruginosa and B. subtilis. The bactericidal effect of P27 
against E. coli and S. aureus was determined by plating suitably di-
luted aliquots of the culture after exposure to different concentrations 
of the peptide for different specified time intervals on nutrient agar 
plates. The plates were incubated for 18 h at 3rC for colony count-
ing. 
Inner membrane permeability of E. coli W160.37 was monitored by 
measuring the J3-galactosidase activity in the cells in stationary phase 
of growth after incubating the cells (in which the enzyme has been 
induced with 5 X 10-4 M IPTG), in the presence of different concen-
trations of the peptides using ONPG as the substrate [17]. Cells in-
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Fig. 1. Primary structure of bovine seminalplasmin and seminalplasmin-related peptides SLS, SPF and P27 corresponding to segments 14-26, 
28-40 and 14-40 of seminalplasmin. 
Table I 
Antimicrobial activity of SPLN-related peptides 
Organism 
E. coli W160-37 
Pseudomonas putida NCIM 2102 
S. aureus PEP 4/3 
B. subtilis 
NA: not active. 
cubated in the absence of the peptide was taken as the control. OD 
measurements were made at 550 nm and 420 nm and 
(A420 -\. 75 X A550) was taken to measure the 13-galactosidase activity. 
2.3. Hemolytic assay 
Erythrocytes from rat were isolated from heparinized blood by 
centrifugation and washed three times with phosphate-buffered saline 
(PBS, 5 mM phosphate buffer containing 0.15 M NaC!, pH 7.4) just 
before assays were performed. Aliquots of cell suspension ( '" 107 /ml) 
in eppendorf tubes were incubated at 37°C with peptides in duplicates 
for 30 min with gentle mixing. The tubes were then centrifuged and 
the absorbance of the supernatants was measured at 540 nm. The lysis 
obtained with 1% Triton X-IOO was considered 100%. 
2.4. Circular dichroism studies 
Spectra were recorded in a Jobin Yvon Mark V Spectropolarimeter. 
Peptides were dissolved at a concentration of 0.1 mM in Hepes buffer, 
pH 7.4, and trifluoroethanol. All spectra were recorded at 25°C and 
data are represented as mean residue ellipticities. Peptide concentra-
tion was quantitated by amino acid analysis. Spectra were deconvo-
luted by the convex constraint analysis (CCA) program kindly pro-
vided by Prof. G.D. Fasman [18]. 
3. Results and discussion 
The antimicrobial spectrum of P27 is presented in Table 1. 
The peptide is more active than the other earlier described 
active shorter synthetic segments of SPLN, SPF [17] and 
SLS [19]. In fact, the potency against E. coli is comparable 
to that of SPLN. The peptide also exhibits activity against 
other microorganisms like SPLN with more or less compar-
able potency. Thus, the peptide spanning residues 14-40 of 
SPLN has antimicrobial activity comparable to that of SPLN, 
unlike the two 13-residue segments that exhibit moderate ac-
tivity, preferentially against E. coli. In order to determine 
whether P27 acts as a bacteriostatic or bactericidal agent, 
the number of viable cells after incubating the E. coli and S. 
aureus in the presence of the peptide, in the case of E. coli and 
S. aureus, was determined. The results are presented in Table 
2. At a peptide concentration of 15 Jlg/ml, E. coli culture is 
virtually sterile in a period of 2 h and in 1 h duration at a 
peptide concentration of 30 Jlg/ml. Similar results were also 
obtained with S. aureus. In order to determine whether P27 
exerts its activity by permeabilizing the bacterial membrane, 
disruption of the E. coli inner membrane in the presence of 
MIC (Il-g/ml) 
SPLN SLS SPF P27 
20-30 60-70 50-60 10-20 
20 NA NA 50-60 
<50 NA NA 40-50 
20-30 NA 100-120 10-20 
the peptide was monitored and the data are presented in Fig. 
2. It is evident that P27 effectively permeabilizes the E. coli 
inner membrane. 
SPLN does not exhibit hemolytic activity even at high con-
centrations (150 Jlg/ml) whereas the 13-residue peptide SPF 
exhibits hemolytic activity at the same concentration range 
as its antimicrobial activity [17]. In the case of P27 whether 
the improved antibacterial activity was accompanied by an 
increase or decrease in hemolytic activity was then examined. 
Fig. 3 shows the hemolytic activity of P27. At its MICs for E. 
coli, S. aureus and B. subtilis, the hemolysis observed is prac-
tically zero. However, above 30 Jlg/ml hemolysis is observed 
with 100% lysis of erythrocytes at 180 Jlg/ml. The peptide 
segments outside the P27 sequence thus appear to have a 
role in determining the specificity of activity. 
In order to examine whether the differences in the specificity 
of activity between P27 and SPLN can be attributed to the 
differences in the conformation of the two peptides, the struc-
ture of SPLN was examined in aqueous environment and 
TFE and the spectra are shown in Fig. 4A,B. In aqueous 
environment P27 is unordered, whereas in TFE it has a pro-
pensity to adopt a-helical structure. Deconvolution of the CD 
spectrum in TFE indicates a helical content of 65%. Fig. 4B 
Table 2 
Bactericidal effects of P27 
Organism 
E. co/i* 
S. aureus* 
Concentration 
of P27 
(Il-g/ml) 
15 
30 
30 
Time of 
incubation 
(min) 
o 
30 
60 
120 
o 
30 
60 
120 
o 
30 
60 
% Viable 
cells 
100 
16 
3 
o 
100 
4 
o 
o 
100 
o 
o 
*5 X 106 CFU of the cells were incubated with different concentrations 
of the peptides in Difco nutrient broth (6 g/L) containing 5 g/L of 
NaC!. 
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Fig. 2. Effect of P27 on the influx of ONPG into E. coli W 160-37. 
Cells were grown in nutrient broth containing 5 X 10-5 M IPTG 
overnight to a A600 of 1.0. Cells in the stationary phase of growth 
were diluted 100 times with phosphate buffer containing ONPG and 
incubated at 37°C with different concentrations of the peptides. The 
absorption at 420 nm and 550 nm were recorded at various time 
points. The value (A420-1.75xA550) was taken to denote ONPG in-
flux. Cells incubated in the absence of any peptide was taken as the 
control. 
indicates that SPLN is more ordered than P27 in aqueous 
environment. However, in TFE, the spectra of the two are 
considerably different. The lower values for SPLN and cross 
over at less than 200 nm would suggest a greater proportion 
of unordered structure. Deconvolution of the spectra indicate 
the presence of ~-sheet and helical conformation in buffer 
with individual contribution of 25 and 4%, respectively, with 
a random contribution - 70%. In TFE, the extent of contri-
bution of component corresponding to a-helical conformation 
increases to 30% with ~-sheet structure contribution - 10%. 
The random contribution is - 50%. SPLN thus appears to 
have lower helical content than P27 with a small fraction 
existing ~-sheet conformation. 
There has been tremendous interest in structure-function 
correlation studies on endogenous antibacterial peptides not 
only with a view to understand their mechanism of action but 
also explore the possibility of using them as therapeutic 
agents. This has been necessary as resistance to clinically 
used antibacterial drugs are a serious problem in clinical med-
icine [20-23]. However, the lengths of the endogenous pep-
tides like cecropins as well as the complex structures like in 
defensins have made it difficult to get short peptides derived 
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Fig. 3. Hemolysis of rat erythrocytes as a function of peptide con-
centration. Erythrocytes (~107/ml) were incubated in phosphate 
buffered (10 mM) isotonic saline containing various concentrations 
of P27 and SPF for 20 min. 
from them with improved or even comparable activity. Sev-
eral short peptides with good activity have indeed been 
synthesized but these are model peptides or hybrids of the 
toxin melittin and antimicrobial peptides [23,24]. In the case 
of SPLN, structure-function studies have lead to the identifi-
cation of a peptide substantially shorter than the parent pep-
tide having comparable antimicrobial activity. Though this 
27-residue peptide does have antibacterial activity, it has he-
molytic properties which SPLN does not have. It should be 
possible to remove this activity by suitable engineering as 
demonstrated for SPF [25]. Thus, P27 along with magainins 
and cecropins should be a good candidate for exploring the 
possibility of using peptides as antibacterial drugs. 
SPLN has recently been shown to be a member of the 
neuropeptide Y gene family [26]. Apart from its antimicrobial 
activity SPLN, alternately known as caltrin [4,27,28], has sev-
eral other properties including Ca2+ transport regulatory ac-
tivity as well as modulation of zona pellucida-induced acro-
some reaction in bovine sperms [29,30]. It has been proposed 
that, although SPLN inhibits spontaneous acrosomal exocy-
tosis by inhibiting the Na+/Ca2+ antiporter pathway, its pres-
ence on the sperm membrane is essential for bringing about 
the physiologically relevant zona pellucida agonist-induced 
acrosomal reaction in bovine sperms [29-31]. It would thus 
be of interest to examine whether P27 would exhibit activities 
15.---------------------, 
B 
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Fig. 4. CD spectra of P27 (0.1 mM) and SPLN (0.1 mM) at 25°C in Hepes buffer (broken line) (5 mM, pH 7.4) and TFE (solid line). (A) 
P27; (B), SPLN. 
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similar to that of caltrin on spermatozoa. Since P27 would be 
easier to obtain by chemical synthesis as compared to SPLN, 
the peptide would serve not only as a good candidate for 
peptide engineering to get antibacterial pep tides with im-
proved activity but also understand the role of SPLN in re-
productive physiology. 
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